Florine A. Eggink
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Reproductive System and Pregnancy, Ovarian cancer diagnosis and treatment
Most-Cited Works
- → POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer(2015)310 cited
- → A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer(2019)254 cited
- → CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma(2016)137 cited
- → Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition(2016)119 cited
- → CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy(2016)68 cited
- → Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands(2016)35 cited
- → Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome(2020)34 cited
- → Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study(2020)34 cited
- → 207 POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer(2015)32 cited
- Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition(2017)